Skip to main content
Caplight Logo









Targepeutics

Targepeutics

Private
Hummelstown, PennsylvaniaHealthcare & Life Scienceshttps://targepeutics.com/

Last Round

Seed

Jul 24, 2025

Company Overview

Targepeutics is a biopharmaceutical company that develops selective molecularly targeted immunotoxin therapies for the treatment of aggressive brain cancers, including glioblastoma and diffuse midline glioma.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting, Government Contracts

AI Layer

Non-AI

Keywords

immunotoxinglioblastomabiopharmaceuticaltargeted therapydiffuse midline gliomaDMGGBMprecision medicinebiologic therapycancer drug developmentoncologyclinical trialsdrug discoverycancer biotechbrain cancer treatment

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Targepeutics Comparables

Compare Targepeutics with similar companies based on industry and business-model similarity.

Targepeutics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Mesenkia Therapeutics AB
78%
MimiVax Inc.
78%
Mustang Bio Inc
77%

Targepeutics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedJul 24, 2025
GrantSep 12, 2022

Key People

Founding team and executive leadership

Sil Lutkewitte

Chief Executive Officer

Executive Team

Targepeutics Investors

Notable investors and investment history

Targepeutics investors
InvestorRounds
National Cancer InstituteGrant
Yuvaan Tiwari FoundationSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 7, 2026

    Monthly visitors increased 102% MoM.

  • Mar 1, 2026

    Monthly visitors increased 118% MoM.

Targepeutics Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Targepeutics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Targepeutics's valuation, stock price, and market status.

Firmographic Details

HeadquartersHummelstown, Pennsylvania
Employee Range5
Year Founded2000
Last FundingJul 24, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?